Navigation Links
GEN reports on growth of biobanking operations
Date:9/19/2012

New Rochelle, NY, September 19, 2012 Many biotech observers maintain that the future of healthcare will largely be based on the field of personalized medicine, reports Genetic Engineering & Biotechnology News (GEN) (http://genengnews.com). Although drug discovery efforts require access to increasingly larger arrays of biosamples, demand is exceeding supply, fueling the growth of the biobanking market, according to a recent issue of GEN (http://genengnews.com/gen-articles/biobanking-confronts-growing-pains/4481).

"Personalized medicine is all about tailoring specific therapies for individual patients," said John Sterling, Editor-in-Chief of GEN. "Scientists are faced with a growing need for biospecimens such as blood, saliva, plasma, and purified DNA to move personalized medicine research forward. Bio-repositories and biobanks will continue to play a critical role in this work."

Sources for human material range from those that provide postmortem material, such as the International Institute for the Advancement of Medicine (IIAM), to consortia that provide samples from living donors with specific diseases, such as the Lung Tissue Research Consortium. Depending on source, varying amounts of donor information are supplied with the human materials.

One key development is the emergence of virtual biobanking, where companies provide a single point of access to a range of biospecimens. Using networks of ethical sources, they find the tissues required to the specifications provided by the requester, and then deliver them to the requester. This streamlines the procurement of tissue and benefits all parties.


'/>"/>
Contact: John Sterling
jsterling@genengnews.com
914-740-2196
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1

Related biology news :

1. GEN reports on recent progress in Alzheimers research
2. BGI reports the latest finding on NMNAT1 mutations linked to Leber congenital amaurosis
3. Aware, Inc. Reports Second Quarter 2012 Financial Results
4. GEN reports on growth of tissue engineering revenues
5. BGI reports the completed sequence of foxtail millet genome
6. Radiologists study necessity of additional imaging recommendations in PET/CT oncologic reports
7. Aware, Inc. Reports First Quarter 2012 Financial Results
8. RUB researchers clarify catalysis mechanism of cell growth protein Ras
9. Smart growth strategies curb car use, greenhouse gas emissions, SF State study suggests
10. Hulk protein, Grb10, controls muscle growth
11. Breast milk promotes a different gut flora growth than infant formulas
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
GEN reports on growth of biobanking operations
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/19/2016)... UAE, April 20, 2016 The ... as a compact web-based "all-in-one" system solution for all ... fingerprint reader or the door interface with integration authorization ... access control systems. The minimal dimensions of the access ... into the building installations offer considerable freedom of design ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology: